Virtual RCG 2020 Header

 

REGISTRATION NOW OPEN!

September 9, 2020

Virtual Red Cell Genotyping 2020: Visionary Solutions

The 10th Annual Symposium is being co-hosted by Versiti and the Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health in Bethesda, MD. This year the symposium will be held virtually.

Please contact belearning@versiti.org with any questions.

 

Click here to view the RCG 2020 Brochure

 

 

This area is for paid participants. The registration fee is $40.00 and payment is processed through Stripe. A Zoom link will be emailed prior to the symposium. Please contact belearning@versiti.org with any questions.

Scientific Committee
Willy A. Flegel, MD – National Institutes of Health, Bethesda, MD
No relationship to disclose

Gregory A. Denomme, PhD, FCSMLS(D) – Versiti, Milwaukee, WI
Disclosures: Grifols, SA - Speaker's Bureau, Honorarium

Activity Director
Jerome L. Gottschall, MD – Versiti, Milwaukee, WI
No relationship to disclose

Symposium Coordinators
Sue Johnson, MSTM, MT(ASCP)SBB – Versiti, Milwaukee, WI
Karen Byrne, MS, MT(ASCP)SBB – National Institutes of Health, Bethesda, MD
Jennifer Zembruski – Versiti, Milwaukee, WI
Coordinators are not involved with content

Scheduled Speakers
Erica Wood, MD – Monash University, Melbourne, Australia

Ross M Fasano, MD – Emory University, Atlanta, GA 

Martin S Ongkeko, MD – NIH Clinical Center, Bethesda, MD
No relationship to disclose

Joseph Cho , MD – Versiti, Milwaukee, WI
No relationship to disclose

Marsha Wheeler, PhD – BloodWorks Northwest, Seattle, WA

Kshitij Srivastava, PhD - NIH Clinical Center, Bethesda, MD 
No relationship to disclose

Gregory A Denomme, PhD, FCSMLS(D) – Versiti, Milwaukee, WI
Disclosures: Grifols, SA- Speaker's Bureau, Honorarium

Willy A Flegel MD – NIH Clinical Center, Bethesda, MD
No relationship to disclose

Eva Hellström-Lindberg, MD Karolinska Institutet, Stockholm, Sweden 
No relationship to disclose

Gerd Blobel, MD, PhD – University of Pennsylvania, Philadelphia, PA
Disclosures: Research support by Pfizer and Sanofi;Consultant for Fulcrum Therapeutics

 

Moderators
Willy A. Flegel, MD – National Institutes of Health, Bethesda, MD
Jennifer Kanakry, MD – NCI, Bethesda, MD
Richard M. Kaufman, MD- Harvard Medical School, Boston, MA
Jerome L. Gottschall, MD – Versiti, Milwaukee, WI
Gregory A DenommePhD, FCSMLS(D) – Versiti, Milwaukee, WI
No relationship to disclose

Faculty Oversight 
Rowena Punzalan, MD - Versiti, Milwaukee, WI
No relationship to disclose

Learning Objectives
1. Discuss how advances in molecular immunohematology are changing patient care.
2. Discuss patient care strategies from examples (vignettes) described during case reviews.
3. Review how the fundamentals of molecular immunohematology are affecting clinical studies.
4. Identify red cell genotyping strategies addressing the need for rare blood. 

ACCME Accreditation Statement:
Versiti is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.

Hours of Participation for Allied Health Care Professionals:

Versiti designates this activity for up to 6 hours of participation for continuing education for allied health professionals.

Versiti is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

 

 

 

This enrollment area is for NIH and FDA employees only and requires a code for enrollment. Please contact : Karen Byrne kbyrne@cc.nih.gov  to access enrollment code. A Zoom link will be emailed prior to the symposium. Please contact belearning@versiti.org with any questions.